Sanz, Y. (2010). Gut microbiota and sulfur compounds: implications for metabolic diseases. Molecular Nutrition & Food Research, 54(S1), S1-S10.
Murrell, D. F., & Mermelstein, R. J. (2016). Emerging therapeutic strategies for IBD: targeting the gut microbiome. Expert Review of Clinical Immunology, 12(1), 99-114.
Kim, J. H., Kim, D. H., Lim, H., Baek, D. Y., Shin, H. K., & Kim, J. K. (2016). El Metilsulfonilmetano suprime las respuestas inflamatorias inducidas por LPS en células RAW 264.7 de macrófagos murinos mediante la vía de señalización NF-κB y STAT3. Revista Biomédica, 39(2), 128-136.
Rapin, J. R., & Wiernsperger, N. (2010). Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. Clinics, 65(6), 635-643.
Barmaki, S., Bohlooli, S., Khoshkhahesh, F., & Haghighian Roudsari, B. (2012). Effect of methylsulfonylmethane supplementation on exercise - Induced muscle damage and total antioxidant capacity in healthy young women. The Journal of Sports Medicine and Physical Fitness, 52(2), 170-174. (Igual que la referencia 4).
Withee, E. D., Tippens, K. M., Dehen, R., Tibbitts, D., Hanes, D., & Zwickey, H. (2017). Effects of Methylsulfonylmethane (MSM) on exercise-induced pain, damage and inflammation in healthy young men and women. Journal of the International Society of Sports Nutrition, 14(Suppl 2), P46.